55513-207 : Mvasi 400 mg/16ml Intravenous Injection, Solution
NDC: | 55513-207 |
Labeler: | Amgen Inc |
Product Type: | Human Prescription Drug |
Drug Name: | Mvasi |
Dosage Form: | Intravenous Injection, Solution |
Application #: | BLA761028 |
Rev. Date: |
NDC Package Codes:
- 55513-207-01: 1 VIAL IN 1 CARTON (55513‑207‑01) > 16 ML IN 1 VIAL
Active Ingredients:
- Bevacizumab
Dosage Strength:
- 400 mg/16mL
Pharmaceutical Classes:
- Vascular Endothelial Growth Factor Inhibitor [EPC]
- Vascular Endothelial Growth Factor Inhibitors [MoA]
- Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]
Related Products:
Based on records with the same trade name.- 55513-206 Mvasi 100 mg/4ml Intravenous Injection, Solution by Amgen Inc
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 55513-206Next: 55513-209 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.